Low 25-hydroxyvitamin D level and adiponectin is associated with insulin sensitivity in large gestational age infants

Cytokine

Volumn 59, Issue 1, 2012, Pages 156-158

  Cekmez, Ferhat ^a   Aydemir, Gokhan ^a   Aydinoz, Secil ^a   Pirgon, Ozgur ^b   Genc, F Alparslan ^a   Tunc, Turan ^a   Sarici, Serdar Umit ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

25 Hydroxyvitamin D; Adiponectin; Insulin resistance; Neonate; Visfatin

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; GLUCOSE; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PARATHYROID HORMONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LARGE FOR GESTATIONAL AGE; MALE; MATERNAL DIABETES MELLITUS; NEWBORN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPONECTIN; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INSULIN RESISTANCE; VITAMIN D;

EID: 84861704823     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.031     Document Type: Article

References (31)

1. Boney C.M., Verma A., Tucker R., et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005, 115:290-296.
2. Lihn A.S., Pedersen S.B., Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005, 6:13-21.
3. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hypersulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.
4. Punthakee Z., Delvin E.E., O'Loughlin J., et al. Adiponectin, adiposity and insulin resistance in children and adolescents. J Clin Endocrinol Metab 2006, 91:2119-2125.
5. Fukuhara A., Matsuda M., Nishizawa M., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 21:426-430.
6. Holick M.F Vitamin D importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004, 79:362-371.
7. Ergür A.T., Berberoĝlu M., Atasay B., şi{dotless}klar Z., Bilir P., Arsan S., et al. Vitamin D deficiency in Turkish mothers and their neonates and in women of reproductive age. J Clin Res Pediatr Endocrinol 2009, 1(6):266-269. [Epub 2009 Nov 3].
8. Boucher B.J. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome X?. Br J Nutr 1998, 79:315-327.
9. Scragg R., Jackson R., Holdaway I., Lim T., Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990, 19:559-563.
10. Fenton T.R. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003, 3:13.
11. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 1985, 28:412-419.
12. Keskin M., Kurtoglu S., Kendirci M., Atabek M.E., Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005, 115:500-503.
13. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
14. Surkan P.J., Hsieh C.C., Johansson A.L., et al. Reasons for increasing trends in large for gestational age births. Obstet Gynecol 2004, 104:720-726.
15. Cekmez F., Canpolat F.E., Pirgon O., çetinkaya M., Aydinoz S., Suleymanoglu S., et al. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance. Cytokine 2011, 56:387-391.
16. Meral C., Cekmez F., Pirgon O., Asya Tanju I., Metin Ipcioglu O., Karademir F., et al. The relationship between serum visfatin, adiponectin, and insulin sensitivity markers in neonates after birth. J Matern Fetal Neonatal Med 2011 Jan, 24(1):166-170. [Epub 2010 May 21].
17. Anand Vaidya, Williams Jonathan S., Forman John P. The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: The NHS and the HPFS. Obesity 2011, 10.1038/oby.2011.210.
18. Nimitphong H., Chanprasertyothin S., Jongjaroenprasert W., Ongphiphadhanakul B. The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 2009, 36:205-210.
19. Gannagé-Yared M.H., Chedid R., Khalife S., Azzi E., Zoghbi F., Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 2009, 160:965-971.
20. Naveh-Many T., Silver J. Vitamin D and the parathyroid 2004, Elsevier, London. 2nd ed.
21. Christakos S., Gabrielides C., Rhoten W.B. Vitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations, and molecular biology. Endocr Rev 1989, 10:3-26.
22. Chiu K.C., Chuang L.M., Lee N.P., Ryu J.M., McGullam J.L., Tsai G.P., et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 2000, 49:1501-1505.
23. Reis J.P., von Muhlen D., Kritz-Silverstein D., Wingard D.L., Barrett-Connor E. Vitamin parathyroid hormone levels and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007, 30:1549-1555.
24. Maestro B., Campion J., Davila N., Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 2000, 47:383-391.
25. Sun X., Zemel M.B. Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity 2007, 15:340-348.
26. Cantorna M.T., Mahon B.D. D-hormone and the immune system. J Rheumatol 2005, 76:11-20.
27. Ruan H., Lodish H.F. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev 2003, 14:447-455.
28. Özkan B., Döneray H., Keskin H. The effect of vitamin D treatment on serum adiponectin levels in children with vitamin D deficiency rickets. J Clin Res Pediatr Endocrinol 2009, 1(6):262-265. [Epub 2009 Nov 2].
29. Kralisch S., Bluher M., Paschke R., Stumvoll M., Fasshauer M. Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome. Mini Rev Med Chem 2007, 7:39-45.
30. Berndt J., Kloting N., Kralisch S., et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005, 54:2911-2916.
31. Hammarstedt A., Pihlajamaki J., Sopasakis V.R., et al. Visfatin is an adipokine but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 2006, 91:1181-1184.